The Fox Chase Chemical Diversity Center, Inc. (FCCDC)

 

The Fox Chase Chemical Diversity Center Announces it Has Been Awarded a Two-Year Research Contract from Intervir

 

Doylestown, PA. December 18, 2018 - FCCDC is pleased to announce that it has been awarded a 2-year research contract from Intervir, a spin-off company associated with the antiviral technology of Prof. Ron Harty of the University of Pennsylvania. This funding is based on a grant from the Wellcome Trust to Intervir.